RDCSB282 2270 3060
DIGEST
The digest printed below was prepared by House Legislative Services. It constitutes no part
of the legislative instrument. The keyword, one-liner, abstract, and digest do not constitute
part of the law or proof or indicia of legislative intent. [R.S. 1:13(B) and 24:177(E)]
SB 282 Reengrossed 2018 Regular Session Mills
Proposed law requires certain health insurance issuers to notify enrollees that they are
subject to an excess consumer cost burden when they are charged more for a prescription
drug than their insurer pays or would pay after considering drug rebates from the drug
manufacturer into the total cost of the drug.
Proposed law requires certain health insurance issuers to certify to the commissioner of
insurance that they passed on to the consumer at least 50% of the rebates received from drug
manufacturers. Proposed law provides that in making this certification all information given
to the commissioner shall be confidential.
Proposed law provides for enforcement against a health insurance issuer's license for failure
to comply with proposed law, or providing a false certification.
Effective August 1, 2018.
(Amends R.S. 44:4.1(B)(11); adds R.S. 22:976)
Summary of Amendments Adopted by Senate
Senate Floor Amendments to engrossed bill
1. Removes provision applying proposed law to pharmacy benefit managers
participating in the Medicaid program.
2. Makes a technical change.
3. Changes definition of "excess consumer cost burden".
Summary of Amendments Adopted by House
The Committee Amendments Proposed by House Committee on Insurance to the
reengrossed bill:
1. Make technical changes.
Page 1 of 1